Expect more with Siegfried as your preferred partner

Bringing together our long-standing pharma and chemical heritage, we offer as an integrated partner benefit to our customers with more synergy, expertise and value. 

Explore more about how our broad range of custom development services, drug substance & drug product manufacturing capabilities, together with our existing product portfolio may help you achieve greater value. 

October 02, 2015

(SIX/SFZN) Siegfried Holding AG today successfully placed a subordinated public hybrid bond in the amount of CHF 100 million. The ... Read more »

September 30, 2015

(SIX/SFZN) Siegfried and BASF concluded the implementation of the agreements on 30 September 2015. Siegfried has thereby acquired ... Read more »

September 30, 2015

(SIX: SFZN) As announced in May 2015, RAG-Stiftung Beteiligungsgesellschaft mbH based in Essen, Germany, will participate in a ... Read more »

SitemapRSS FeedsDisclaimer